Skip to main content
Smart Investors Daily
ES

OTC · ESLOY

EssilorLuxottica S.A.

Healthcare · Medical - Instruments & Supplies

$102.66

Up+$2.86 (+2.87%)

Updated Oct 31, 2026, 12:28 AM

SID Score

4.6/10

Composite research score

Smart Money

46/100

Neutral

Market cap
152.72B
P/E ratio
54.42
Dividend yield
2.20%
52-week range
$79.27 – $186.81
Volume
206.72K
Avg. volume
53.93K

Price performance · ESLOY

ESLOY price history

1M range · 6 trading sessions · Daily adjusted prices

Prices through Oct 9, 2026

ESLOY closed at $82.26 after 6 trading sessions, up 2.00% for the selected period.

Last close
$82.26
Period change
+2.00%
Period low
$80.65
Period high
$82.26
Daily close
View OHLC price history
ESLOY OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 9, 2026$82.13$82.596$81.295$82.26206.72K
Oct 8, 2026$80.73$80.93$79.845$80.87126.39K
Oct 7, 2026$81.73$82.17$81.12$82.17170.95K
Oct 6, 2026$81.72$82.79$81.4175$82.03198.15K
Oct 5, 2026$80.86$81.49$80.59$81.44213.11K
Oct 2, 2026$82.15$82.158$80.24$80.65131.23K

Latest ESLOY news

The latest Smart Investors Daily articles mentioning ESLOY.

ESLOY research

Overview

Company profile and research snapshot.

Company profile

ESSILOR LXTTCA UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
—
Implied upside
—
Analysts
12
ESLOY recent ratings
DateFirmRatingTarget
Sep 23, 2026LANDESBANK BADEN-WUERTTEMBERGBuy—
Sep 21, 2026DAY BY DAYSell—
Sep 21, 2026EQUITA SIMBuy—
Sep 18, 2026STIFEL EUROPEBuy—
Sep 15, 2026JEFFERIESBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 23, 2026

S&P upgrades EssilorLuxottica to ’A+’ on strength of medtech pivot

Investing.com -- S&P Global Ratings has upgraded EssilorLuxottica SA's (EPA:ESLX) long-term issuer credit rating to ‘A+’ from ‘A’, citing the company's successful pivot from a traditional consumer goods business into an integrated medtech leader. The rating agency affirmed the group's 'A-1' short-term rating while assigning a stable outlook, reflecting expectations that core vision care demand will continue to shield the group from broader macroeconomic headwinds.

Yahoo · Oct 22, 2026

EssilorLuxottica Stock Revenue Beat Signals Strength In Wearables And Direct Sales

EssilorLuxottica Société anonyme reported third quarter 2026 revenue of €7,486 million, up 7.2% at constant exchange rates and 9.0% at current rates, with group revenue for the first nine months at €22,304 million, up 6.8% or 8.9% at constant exchange rates versus the same period of 2025. The business saw broadbased support from all regions, faster expansion in Asia Pacific, and strong contributions from wearables, myopia management products, and direct to consumer channels. Together, these...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.